BiotechTube
Home/Revel Pharmaceuticals/Aaron Cravens, PhD
AC

Aaron Cravens, PhD

Co-Founder & CEO

Revel Pharmaceuticals

Therapeutic Areas

AgingChronic IllnessAutoimmunity

Revel Pharmaceuticals Pipeline

DrugIndicationPhase
Toxic Metabolite Clearance PlatformAge-related diseases (e.g., diabetic complications, neurodegeneration)Preclinical

Leadership Team at Revel Pharmaceuticals

JC
Jason Crawford, PhD
Co-Founder & Scientific Advisor
VM
Vincent Monnier, MD
Scientific Advisor
RH
Ram H. Nagaraj, PhD
Scientific Advisor
KI
Kenneth I. Moch, MBA
Scientific & Business Advisor
View full Revel Pharmaceuticals profile